BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37041267)

  • 1. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
    Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
    Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
    Yu Y; Liang C; Tang Q; Shi Y; Shen L
    Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
    Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
    BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
    Liang C; Wang S; Zhang M; Li T
    J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of m6A regulator-mediated RNA methylation modification patterns and key immune-related genes involved in atrial fibrillation.
    Zheng PF; Zhou SY; Zhong CQ; Zheng ZF; Liu ZY; Pan HW; Peng JQ
    Aging (Albany NY); 2023 Feb; 15(5):1371-1393. PubMed ID: 36863715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
    Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
    J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of m6A Regulator Genes can Facilitate the Diagnosis of Chronic Heart Failure.
    Zhou F; Yu Y; Li Y; Chen J; Wen S; Liu N; Li X; Bai R; Yan W
    Heart Surg Forum; 2023 Oct; 26(5):E485-E497. PubMed ID: 37920080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key m
    Zhang Y; Qi C; Guo Y; Li X; Zhu Z
    BMC Med Genomics; 2023 Dec; 16(1):314. PubMed ID: 38049811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction.
    Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C
    J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma.
    Sun D; Yang H; Fan L; Shen F; Wang Z
    J Cell Mol Med; 2021 Nov; 25(21):10236-10247. PubMed ID: 34647423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
    Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
    Front Immunol; 2022; 13():976107. PubMed ID: 36091006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer.
    Zhao H; Xu Y; Xie Y; Zhang L; Gao M; Li S; Wang F
    Front Cell Dev Biol; 2021; 9():650023. PubMed ID: 33748145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
    Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
    Front Neurol; 2022; 13():889141. PubMed ID: 35989938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
    Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
    Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
    Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
    Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
    Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
    FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A Regulator-Mediated RNA Methylation Modification Patterns Regulate the Immune Microenvironment in Osteoarthritis.
    Duan Y; Yu C; Yan M; Ouyang Y; Ni S
    Front Genet; 2022; 13():921256. PubMed ID: 35812736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
    Zhou S; Hua R; Quan S
    J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease.
    Chen JY; Xiong T; Sun YR; Cong J; Gong JS; Peng L; Rong YW; Wang ZY; Chang Q
    Ann Transl Med; 2022 Sep; 10(17):931. PubMed ID: 36172101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.